Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$750K Buy
5,834
+218
+4% +$25.5K 0.12% 158
2026
Q1
$676K Sell
5,616
-188
-3% -$21.7K 0.13% 146
2025
Q4
$611K Sell
5,804
-1,281
-18% -$120K 0.13% 143
2025
Q3
$595K Buy
7,085
+103
+1% +$8.48K 0.16% 110
2025
Q2
$553K Buy
6,982
+349
+5% +$27.7K 0.16% 113
2025
Q1
$595K Sell
6,633
-94
-1% -$8.78K 0.2% 89
2024
Q4
$669K Sell
6,727
-224
-3% -$23.1K 0.24% 79
2024
Q3
$789K Buy
6,951
+1,144
+20% +$136K 0.33% 62
2024
Q2
$766K Hold
5,807
0.59% 48
2024
Q1
$766K Buy
5,807
+53
+0.9% +$6.53K 0.58% 48
2023
Q4
$627K Buy
+5,754
New +$597K 0.53% 52

Other funds holding MRK

Holistic Planning's MRK Position: Q2 2026 in Review

Holistic Planning increased its Merck (MRK) stake by 3.9% in Q2 2026, buying an estimated $25.5K and bringing the position to 5,834 shares worth $750K. The position accounts for 0.12% of the portfolio, ranked #158.

Holistic Planning first reported a position in MRK in Q4 2023 and has held it in 11 quarters since. The position peaked at $789K in Q3 2024. 3,833 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Holistic Planning held 5,834 shares of Merck worth $750K as of Q2 2026.
  • Holistic Planning bought 218 Merck shares in Q2 2026, an estimated $25.5K.
  • Merck made up 0.12% of Holistic Planning's portfolio in Q2 2026, its #158 holding.
  • Holistic Planning first reported a position in Merck in Q4 2023 and has held it in 11 quarters since.
  • Holistic Planning's Merck position peaked at $789K in Q3 2024.
  • 3,833 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Holistic Planning's 13F filing for Q2 2026, filed 10 Aug 2026.